Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone

Anna L. Godfrey, Edwin Chen, Francesca Pagano, Christina A. Ortmann, Yvonne Silber, Beatriz Bellosillo, Paola Guglielmelli, Claire N. Harrison, John T. Reilly, Frank Stegelmann, Fontanet Bijou, Eric Lippert, Mary F. McMullin, Jean-Michel Boiron, Konstanze Döhner, Alessandro M. Vannucchi, Carlos Besses, Peter J. Campbell, Anthony R. Green

Blood (2012) 120 (13): 2704–2707.

https://doi.org/10.1182/blood-2012-05-431791

Published: 2012

Includes: Supplemental data

Journal Articles

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference

Giovanni Barosi, Gunnar Birgegard, Guido Finazzi, Martin Griesshammer, Claire Harrison, Hans Carl Hasselbalch, Jean-Jacques Kiladjian, Eva Lengfelder, Mary Frances McMullin, Francesco Passamonti, John T. Reilly, Alessandro M. Vannucchi, Tiziano Barbui

Blood (2009) 113 (20): 4829–4833.

https://doi.org/10.1182/blood-2008-09-176818

Published: 2009

Journal Articles

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean-Loup Demory, Giovanni Barosi, Elisa Rumi, Ayalew Tefferi

Blood (2009) 113 (13): 2895–2901.

https://doi.org/10.1182/blood-2008-07-170449

Published: 2009

Includes: Supplemental data

Journal Articles

A New Prognostic Scoring System for Primary Myelofibrosis Based on a Study of the International Working Group for Myelofibrosis Research and Treatment

Francisco Cervantes, MD, Brigitte Dupriez, MD, Arturo Pereira, MD, Francesco Passamonti, MD, John T Reilly, MD, Enrica Morra, MD, Alessandro Vannucchi, MD, Ruben A. Mesa, MD, FACP, Jean-Loup Demory, MD, Giovanni Barosi, MD, Elisa Rumi, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 657.

https://doi.org/10.1182/blood.V112.11.657.657

Published: 2008

Journal Articles

Outcomes of Patients with Haematological Malignancies Admitted to Either High Dependency Unit (HDU) or Intensive Care Unit (ICU) with or without Haemopoeitic Stem Cell Transplantation (HSCT): Analysis of Prognostic Factors for Survival

Youssef Sorour, Stephen J Webber, Josh G Wright, Nicholas J Morley, John T Reilly, Christopher D Dalley, John A Snowden

Blood (2008) 112 (11): 2391.

https://doi.org/10.1182/blood.V112.11.2391.2391

Published: 2008

Journal Articles

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, Anthony R. Green

Blood (2008) 112 (1): 141–149.

https://doi.org/10.1182/blood-2008-01-131664

Published: 2008

Includes: Supplemental data

Journal Articles

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Ayalew Tefferi, Juergen Thiele, Attilio Orazi, Hans Michael Kvasnicka, Tiziano Barbui, Curtis A. Hanson, Giovanni Barosi, Srdan Verstovsek, Gunnar Birgegard, Ruben Mesa, John T. Reilly, Heinz Gisslinger, Alessandro M. Vannucchi, Francisco Cervantes, Guido Finazzi, Ronald Hoffman, D. Gary Gilliland, Clara D. Bloomfield, James W. Vardiman

Blood (2007) 110 (4): 1092–1097.

https://doi.org/10.1182/blood-2007-04-083501

Published: 2007

Journal Articles

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Peter J. Campbell, E. Joanna Baxter, Philip A. Beer, Linda M. Scott, Anthony J. Bench, Brian J. P. Huntly, Wendy N. Erber, Rajko Kusec, Thomas Stauffer Larsen, Stéphane Giraudier, Marie-Caroline Le Bousse-Kerdilès, Martin Griesshammer, John T. Reilly, Betty Y. Cheung, Claire N. Harrison, Anthony R. Green

Blood (2006) 108 (10): 3548–3555.

https://doi.org/10.1182/blood-2005-12-013748

Published: 2006

Journal Articles

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)

Blood (2006) 108 (5): 1497–1503.

https://doi.org/10.1182/blood-2006-03-009746

Published: 2006

Journal Articles

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Blood (2006) 107 (5): 2098–2100.

https://doi.org/10.1182/blood-2005-08-3395

Published: 2006

Journal Articles

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Giovanni Barosi, Dominique Bordessoule, Jean Briere, Francisco Cervantes, Jean-Loup Demory, Brigitte Dupriez, Heinz Gisslinger, Martin Griesshammer, Hans Hasselbalch, Rajko Kusec, Marie-Caroline Le Bousse-Kerdiles, Nicola L. Liberato, Monia Marchetti, John T. Reilly, Jurgen Thiele

Blood (2005) 106 (8): 2849–2853.

https://doi.org/10.1182/blood-2005-04-1520

Published: 2005

Journal Articles

Promoter Methylation of RASSFIA , SHP1 and SOCS1 Genes in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS).

M. Farid Johan, Anne C. Goodeve, David T. Bowen, John T. Reilly

Blood (2004) 104 (11): 2999.

https://doi.org/10.1182/blood.V104.11.2999.2999

Published: 2004

Journal Articles

FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia

Faisal M. Abu-Duhier, Anne C. Goodeve, Gill A. Wilson, Rory S. Carr, Ian R. Peake, John T. Reilly

Blood (2002) 100 (1): 364.

https://doi.org/10.1182/blood-2002-02-0536

Published: 2002

NARROW

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

A New Prognostic Scoring System for Primary Myelofibrosis Based on a Study of the International Working Group for Myelofibrosis Research and Treatment

Outcomes of Patients with Haematological Malignancies Admitted to Either High Dependency Unit (HDU) or Intensive Care Unit (ICU) with or without Haemopoeitic Stem Cell Transplantation (HSCT): Analysis of Prognostic Factors for Survival

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT)

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Promoter Methylation of RASSFIA , SHP1 and SOCS1 Genes in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS).

FLT3 internal tandem duplication mutations are rare in agnogenic myeloid metaplasia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only